123 related articles for article (PubMed ID: 8105942)
1. Calcium mass transfer and kinetics in CAPD using calcium-free solutions.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1993; 9():274-9. PubMed ID: 8105942
[TBL] [Abstract][Full Text] [Related]
2. Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium/magnesium and high lactate dialysis fluid.
Merchant MR; Hutchinson AJ; Butler SJ; Boulton H; Hintchliffe R; Gokal R
Adv Perit Dial; 1992; 8():365-8. PubMed ID: 1361824
[TBL] [Abstract][Full Text] [Related]
3. Calcium mass transfer with 10-hour dwell time using 1.25 versus 1.75 mmol/L calcium dialysate.
Banalagay EE; Bernardini J; Piraino B
Adv Perit Dial; 1993; 9():271-3. PubMed ID: 8105941
[TBL] [Abstract][Full Text] [Related]
4. Calcium mass transfer in CAPD: the role of convective transport.
Montenegro J; Saracho R; Aguirre R; Martinez I
Nephrol Dial Transplant; 1993; 8(11):1234-6. PubMed ID: 8302462
[TBL] [Abstract][Full Text] [Related]
5. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
Bro S; Brandi L; Olgaard K
Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
[TBL] [Abstract][Full Text] [Related]
6. Transperitoneal calcium mass transfer using dialysate with a low calcium concentration (1.0 mM).
Weinreich T; Colombi A; Echterhoff HH; Mielke G; Nebel M; Ziegelmayer C; Passlick-Deetjen J
Perit Dial Int; 1993; 13 Suppl 2():S467-70. PubMed ID: 8399641
[TBL] [Abstract][Full Text] [Related]
7. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
Cheng IK; Lu HB; Chan CY; Cheng SW; Robinson JD; Tam SC; Lo WK; Cheung WC
Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
[TBL] [Abstract][Full Text] [Related]
8. [Non-pharmacological calcium metabolism control in patients undergoing hemodialysis].
Malberti F
G Ital Nefrol; 2009; 26(6):670-8. PubMed ID: 19918749
[TBL] [Abstract][Full Text] [Related]
9. [Relative hypoparathyroidism associated with CAPD treatment using normo-calcemic (3.5mEq/1) dialysate: an approach from transperitoneal calcium balance].
Shigematsu T; Hasegawa T; Utsunomiya M; Kubo H; Kato N; Hayakawa H; Yamamoto H; Nakayama M; Ogawa A; Kawaguchi Y
Nihon Jinzo Gakkai Shi; 1995 Mar; 37(3):172-8. PubMed ID: 7731105
[TBL] [Abstract][Full Text] [Related]
10. Calcium mass transfer in peritoneal dialysis patients using 2.5 mEq/l calcium dialysate.
Piraino B; Bernardini J; Holley J; Johnston JR; Perlmutter JA; Martis L
Clin Nephrol; 1992 Jan; 37(1):48-51. PubMed ID: 1541065
[TBL] [Abstract][Full Text] [Related]
11. Ultrafiltration failure and dialysate glucose in CAPD.
Stegmayr B; Granbom L; Karlsson UM; Lindqvist B
Adv Perit Dial; 1993; 9():62-4. PubMed ID: 8105964
[TBL] [Abstract][Full Text] [Related]
12. Transport kinetics of pseudouridine during hemodialysis and continuous ambulatory peritoneal dialysis.
Struijk DG; Schoots AC; Koole LH; van der Reijden HJ; Koomen GC; Krediet RT; Arisz L
J Lab Clin Med; 1991 Jul; 118(1):74-80. PubMed ID: 2066647
[TBL] [Abstract][Full Text] [Related]
13. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
[TBL] [Abstract][Full Text] [Related]
14. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD.
Heimbürger O; Waniewski J; Werynski A; Park MS; Lindholm B
Nephrol Dial Transplant; 1994; 9(1):47-59. PubMed ID: 8177476
[TBL] [Abstract][Full Text] [Related]
15. Mass transfer of calcium across the peritoneum at three different peritoneal dialysis fluid Ca2+ and glucose concentrations.
Simonsen O; Venturoli D; Wieslander A; Carlsson O; Rippe B
Kidney Int; 2003 Jul; 64(1):208-15. PubMed ID: 12787411
[TBL] [Abstract][Full Text] [Related]
16. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
Cara M; Virga G; Mastrosimone S; Girotto A; Rossi V; D'Angelo A; Bonfante L
J Nephrol; 2005; 18(1):67-71. PubMed ID: 15772925
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
18. Amino-acid-based dialysis solution changes leptinemia and leptin peritoneal clearance.
Grzegorzewska AE; Wiecek A; Mariak I; Kokot F
Adv Perit Dial; 2000; 16():7-14. PubMed ID: 11045252
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal functional changes induced by dialysate containing bicarbonate instead of lactate.
Selgas R; Bajo MA; Fernandez-Reyes MJ; Jimenez C; Del Peso G; Sanchez C; de Alvaro F
Adv Perit Dial; 1996; 12():49-52. PubMed ID: 8865872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]